In recent years, several medications have gained popularity for their effectiveness in aiding weight loss
Importantly, these medications treat obesity as an ongoing condition: research consistently shows that much of the lost weight is regained when treatment stops, so they are intended for long-term use paired with sustained lifestyle changes and regular follow-up
The Cautious Conversation: Potential Risks and Concerns While the potential benefits are compelling, there are important safety considerations to address: Drug-Induced Lupus: A handful of case reports have raised concerns about a potential link between GLP-1 drugs and drug-induced lupus (DIL), a condition that mimics the symptoms of lupus and typically resolves after the medication is stopped
The subsequent reduction in membrane-bound TREM2 impairs macrophage efferocytosis, sustains chronic inflammation, and contributes to the progression from simple steatosis to MASH (67)
Lab testing and clinical history help guide this decision
Anxiolytic effect of BPC-157, a gastric pentadecapeptide: shock probe/burying test and light/dark test